| Viruses as quasispecies: biological implications E Domingo, V Martin, C Perales, A Grande-Perez, J Garcia-Arriaza, ... Quasispecies: concept and implications for virology, 51-82, 2006 | 342 | 2006 |
| The evolution of poxvirus vaccines L Sánchez-Sampedro, B Perdiguero, E Mejías-Pérez, J García-Arriaza, ... Viruses 7 (4), 1726-1803, 2015 | 244 | 2015 |
| Evolutionary transition toward defective RNAs that are infectious by complementation J García-Arriaza, SC Manrubia, M Toja, E Domingo, C Escarmís Journal of virology 78 (21), 11678-11685, 2004 | 194 | 2004 |
| A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection J García-Arriaza, V Cepeda, D Hallengärd, CÓS Sorzano, BM Kümmerer, ... Journal of Virology 88 (6), 3527-3547, 2014 | 148 | 2014 |
| Viral genome segmentation can result from a trade-off between genetic content and particle stability S Ojosnegros, J Garcia-Arriaza, C Escarmis, SC Manrubia, C Perales, ... PLoS genetics 7 (3), e1001344, 2011 | 118 | 2011 |
| COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike protein induce robust T-and B-cell immune responses and full efficacy in mice J García-Arriaza, U Garaigorta, P Pérez, A Lázaro-Frías, C Zamora, ... Journal of virology 95 (7), 10.1128/jvi. 02260-20, 2021 | 103 | 2021 |
| Enhancing poxvirus vectors vaccine immunogenicity J García-Arriaza, M Esteban Human vaccines & immunotherapeutics 10 (8), 2235-2244, 2014 | 103 | 2014 |
| The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens CE Gómez, JL Nájera, B Perdiguero, J García-Arriaza, COS Sorzano, ... Journal of virology 85 (21), 11468-11478, 2011 | 103 | 2011 |
| Poxvirus vectors as HIV/AIDS vaccines in humans C Elena Gomez, B Perdiguero, J García-Arriaza, M Esteban Human vaccines & immunotherapeutics 8 (9), 1192-1207, 2012 | 97 | 2012 |
| Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus P Roques, K Ljungberg, BM Kümmerer, L Gosse, N Dereuddre-Bosquet, ... JCI insight 2 (6), 2017 | 92 | 2017 |
| Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions J García-Arriaza, JL Nájera, CE Gómez, COS Sorzano, M Esteban PLoS One 5 (8), e12395, 2010 | 88 | 2010 |
| Clinical applications of attenuated MVA poxvirus strain CE Gómez, B Perdiguero, J García-Arriaza, M Esteban Expert review of vaccines 12 (12), 1395-1416, 2013 | 87 | 2013 |
| Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1 … F García, JCLB de Quirós, CE Gómez, B Perdiguero, JL Nájera, ... Vaccine 29 (46), 8309-8316, 2011 | 87 | 2011 |
| Prime-boost immunization strategies against Chikungunya virus D Hallengärd, FM Lum, BM Kümmerer, A Lulla, V Lulla, J García-Arriaza, ... Journal of virology 88 (22), 13333-13343, 2014 | 83 | 2014 |
| A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses J García-Arriaza, JL Nájera, CE Gómez, N Tewabe, COS Sorzano, ... PLoS One 6 (8), e24244, 2011 | 83 | 2011 |
| Rapid selection in modified BHK-21 cells of a foot-and-mouth disease virus variant showing alterations in cell tropism C Escarmís, EC Carrillo, M Ferrer, JFG Arriaza, N Lopez, C Tami, ... Journal of virology 72 (12), 10171-10179, 1998 | 81 | 1998 |
| Improving adaptive and memory immune responses of an HIV/AIDS vaccine candidate MVA-B by deletion of vaccinia virus genes (C6L and K7R) blocking interferon signaling pathways J García-Arriaza, P Arnáez, CE Gómez, CÓS Sorzano, M Esteban PloS one 8 (6), e66894, 2013 | 79 | 2013 |
| Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens JL Nájera, CE Gómez, J Garcia-Arriaza, CO Sorzano, M Esteban PLoS one 5 (6), e11406, 2010 | 77 | 2010 |
| Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1 B Mothe, N Climent, M Plana, M Rosàs, JL Jiménez, ... Journal of Antimicrobial Chemotherapy 70 (6), 1833-1842, 2015 | 73 | 2015 |
| Dynamics of mutation and recombination in a replicating population of complementing, defective viral genomes J García-Arriaza, S Ojosnegros, M Dávila, E Domingo, C Escarmís Journal of molecular biology 360 (3), 558-572, 2006 | 60 | 2006 |
